Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Obese Patients With Accelerated Gastric Emptying
NCT02160990Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2014
- Primary completion
- Mar 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in obesity, sponsored by Mayo Clinic. Started Jun 2014; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02160990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160990.